Dnajb8, a member of the heat shock protein 40 family has a role in the tumor initiation and resistance to docetaxel but is dispensable for stress response

PLoS ONE

Volumn 11, Issue 1, 2016, Pages

  Yamashita, Masamichi ^a,b   Hirohashi, Yoshihiko ^a   Torigoe, Toshihiko ^a   Kusumoto, Hiroki ^a   Murai, Aiko ^a   Imagawa, Tomohiro ^b   Sato, Noriyuki ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DNAJ HOMOLOG SUBFAMILY B MEMBER 8; DOCETAXEL; GLUCOSE; HEAT SHOCK PROTEIN 40; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; CHAPERONE; DNAJB8 PROTEIN, HUMAN; DNAJB8 PROTEIN, MOUSE; NERVE PROTEIN; SMALL INTERFERING RNA; TAXOID;

ANALYTICAL PARAMETERS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER STEM LIKE CELL; CARCINOGENESIS; CELL STRESS; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG RESISTANCE; DRUG SENSITIVITY; FEMALE; GENE INACTIVATION; HEAT SHOCK; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KIDNEY CARCINOMA; KNOCKOUT MOUSE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PH; PROTEIN FUNCTION; SIDE POPULATION RATIO; SPHERE FORMATION; WILD TYPE; ANIMAL; BAGG ALBINO MOUSE; CANCER STEM CELL; CANCER TRANSPLANTATION; CELL DIFFERENTIATION; CELL TRANSFORMATION; CHEMISTRY; CRISPR CAS SYSTEM; CYTOLOGY; KIDNEY NEOPLASMS; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHYSIOLOGICAL STRESS; SIDE POPULATION CELL; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; BASE SEQUENCE; CARCINOMA, RENAL CELL; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CISPLATIN; CRISPR-CAS SYSTEMS; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE KNOCKOUT TECHNIQUES; GLUCOSE; HSP40 HEAT-SHOCK PROTEINS; HUMANS; HYDROGEN-ION CONCENTRATION; KIDNEY NEOPLASMS; MICE; MICE, INBRED BALB C; MOLECULAR CHAPERONES; MOLECULAR SEQUENCE DATA; NEOPLASM TRANSPLANTATION; NEOPLASTIC STEM CELLS; NERVE TISSUE PROTEINS; RNA, SMALL INTERFERING; SIDE-POPULATION CELLS; STRESS, PHYSIOLOGICAL; TAXOIDS;

EID: 84954465959     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0146501     Document Type: Article

References (31)

1. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL, et al. Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer research. 2006; 66(19):9339-44. Epub 2006/09/23. doi: 10.1158/0008-5472.CAN-06-3126 PMID: 16990346.
2. Visvader JE, Lindeman GJ. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer. 2008; 8(10):755-68. nrc2499 [pii] doi: 10.1038/nrc2499 PMID: 18784658.
3. Park CY, Tseng D, Weissman IL. Cancer stem cell-directed therapies: recent data from the laboratory and clinic. Molecular therapy: the journal of the American Society of Gene Therapy. 2009; 17(2):219-30. Epub 2008/12/11. doi: 10.1038/mt.2008.254 PMID: 19066601; PubMed Central PMCID: PMC2835048.
4. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature. 1994; 367(6464):645-8. doi: 10.1038/367645a0 PMID: 7509044.
5. Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. The Journal of experimental medicine. 1996; 183 (4):1797-806. PMID: 8666936; PubMed Central PMCID: PMCPMC2192511.
6. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proceedings of the National Academy of Sciences of the United States of America. 2003; 100(7):3983-8. Epub 2003/03/12. doi: 10.1073/pnas.0530291100 PMID: 12629218; PubMed Central PMCID: PMC153034.
7. Hageman J, Rujano MA, van Waarde MA, Kakkar V, Dirks RP, Govorukhina N, et al. A DNAJB chaperone subfamily with HDAC-dependent activities suppresses toxic protein aggregation. Molecular cell. 2010; 37(3):355-69. Epub 2010/02/18. doi: 10.1016/j.molcel.2010.01.001 PMID: 20159555.
8. Gillis J, Schipper-Krom S, Juenemann K, Gruber A, Coolen S, van den Nieuwendijk R, et al. The DNAJB6 and DNAJB8 protein chaperones prevent intracellular aggregation of polyglutamine peptides. The Journal of biological chemistry. 2013; 288(24):17225-37. Epub 2013/04/25. doi: 10.1074/jbc. M112.421685 PMID: 23612975; PubMed Central PMCID: PMC3682527.
9. Sterrenberg JN, Blatch GL, Edkins AL. Human DNAJ in cancer and stem cells. Cancer Lett. 2011; 312 (2):129-42. Epub 2011/09/20. doi: 10.1016/j.canlet.2011.08.019 PMID: 21925790.
10. Nishizawa S, Hirohashi Y, Torigoe T, Takahashi A, Tamura Y, Mori T, et al. HSP DNAJB8 Controls Tumor-Initiating Ability in Renal Cancer Stem-like Cells. Cancer research. 2012; 72(11):2844-54. Epub 2012/05/04. doi: 10.1158/0008-5472.CAN-11-3062 PMID: 22552285.
11. Morita R, Nishizawa S, Torigoe T, Takahashi A, Tamura Y, Tsukahara T, et al. Heat shock protein DNAJB8 is a novel target for immunotherapy of colon cancer-initiating cells. Cancer science. 2014; 105 (4):389-95. Epub 2014/01/24. doi: 10.1111/cas.12362 PMID: 24450541.
12. Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F. Genome engineering using the CRISPRCas9 system. Nature protocols. 2013; 8(11):2281-308. Epub 2013/10/26. doi: 10.1038/nprot.2013.143 PMID: 24157548; PubMed Central PMCID: PMC3969860.
13. Nakatsugawa M, Hirohashi Y, Torigoe T, Asanuma H, Takahashi A, Inoda S, et al. Novel spliced form of a lens protein as a novel lung cancer antigen, Lengsin splicing variant 4. Cancer science. 2009; 100 (8):1485-93. Epub 2009/05/23. doi: 10.1111/j.1349-7006.2009.01187.x PMID: 19459848.
14. Yasuda K, Torigoe T, Mariya T, Asano T, Kuroda T, Matsuzaki J, et al. Fibroblasts induce expression of FGF4 in ovarian cancer stem-like cells/cancer-initiating cells and upregulate their tumor initiation capacity. Laboratory investigation; a journal of technical methods and pathology. 2014. Epub 2014/10/21. doi: 10.1038/labinvest.2014.122 PMID: 25329002.
15. Gaj T, Gersbach CA, Barbas CF 3rd. ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends in biotechnology. 2013; 31(7):397-405. Epub 2013/05/15. doi: 10.1016/j.tibtech.2013. 04.004 PMID: 23664777; PubMed Central PMCID: PMC3694601.
16. Yuan X, Curtin J, Xiong Y, Liu G, Waschsmann-Hogiu S, Farkas DL, et al. Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene. 2004; 23(58):9392-400. Epub 2004/11/24. doi: 10.1038/sj.onc.1208311 PMID: 15558011.
17. Kondo T, Setoguchi T, Taga T. Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proceedings of the National Academy of Sciences of the United States of America. 2004; 101(3):781-6. Epub 2004/01/09. doi: 10.1073/pnas.0307618100 PMID: 14711994; PubMed Central PMCID: PMC321758.
18. Nakatsugawa M, Takahashi A, Hirohashi Y, Torigoe T, Inoda S, Murase M, et al. SOX2 is overexpressed in stem-like cells of human lung adenocarcinoma and augments the tumorigenicity. Laboratory investigation; a journal of technical methods and pathology. 2011; 91(12):1796-804. Epub 2011/09/21. doi: 10.1038/labinvest.2011.140 PMID: 21931300.
19. Kreso A, van Galen P, Pedley NM, Lima-Fernandes E, Frelin C, Davis T, et al. Self-renewal as a therapeutic target in human colorectal cancer. Nature medicine. 2014; 20(1):29-36. Epub 2013/12/03. doi: 10.1038/nm.3418 PMID: 24292392.
20. Ohtsuka K, Hata M. Mammalian HSP40/DNAJ homologs: cloning of novel cDNAs and a proposal for their classification and nomenclature. Cell Stress Chaperones. 2000; 5(2):98-112. Epub 2001/01/09. PMID: 11147971; PubMed Central PMCID: PMC312896.
21. Capecchi MR. Altering the genome by homologous recombination. Science. 1989; 244(4910):1288-92. Epub 1989/06/16. PMID: 2660260.
22. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 2001; 411(6836):494-8. Epub 2001/05/25. doi: 10.1038/35078107 PMID: 11373684.
23. Wang H, Yang H, Shivalila CS, Dawlaty MM, Cheng AW, Zhang F, et al. One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome Engineering. Cell. 2013; 153 (4):910-8. Epub 2013/05/07. doi: 10.1016/j.cell.2013.04.025 PMID: 23643243.
24. Bylund M, Andersson E, Novitch BG, Muhr J. Vertebrate neurogenesis is counteracted by Sox1-3 activity. Nature neuroscience. 2003; 6(11):1162-8. Epub 2003/10/01. doi: 10.1038/nn1131 PMID: 14517545.
25. Fan X, Matsui W, Khaki L, Stearns D, Chun J, Li YM, et al. Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors. Cancer research. 2006; 66(15):7445-52. Epub 2006/08/04. doi: 10.1158/0008-5472.CAN-06-0858 PMID: 16885340.
26. Sikandar SS, Pate KT, Anderson S, Dizon D, Edwards RA, Waterman ML, et al. NOTCH signaling is required for formation and self-renewal of tumor-initiating cells and for repression of secretory cell differentiation in colon cancer. Cancer research. 2010; 70(4):1469-78. Epub 2010/02/11. doi: 10.1158/0008-5472.CAN-09-2557 PMID: 20145124.
27. Park IK, Qian D, Kiel M, Becker MW, Pihalja M, Weissman IL, et al. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature. 2003; 423(6937):302-5. Epub 2003/04/26. doi: 10.1038/nature01587 PMID: 12714971.
28. Molofsky AV, Pardal R, Iwashita T, Park IK, Clarke MF, Morrison SJ. Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature. 2003; 425(6961):962-7. Epub 2003/10/24. doi: 10.1038/nature02060 PMID: 14574365; PubMed Central PMCID: PMC2614897.
29. Liu S, Dontu G, Mantle ID, Patel S, Ahn NS, Jackson KW, et al. Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer research. 2006; 66 (12):6063-71. Epub 2006/06/17. doi: 10.1158/0008-5472.CAN-06-0054 PMID: 16778178.
30. Chen YC, Chang CJ, Hsu HS, Chen YW, Tai LK, Tseng LM, et al. Inhibition of tumorigenicity and enhancement of radiochemosensitivity in head and neck squamous cell cancer-derived ALDH1-positive cells by knockdown of Bmi-1. Oral oncology. 2010; 46(3):158-65. Epub 2009/12/29. doi: 10.1016/j. oraloncology.2009.11.007 PMID: 20036608.
31. Dai C, Whitesell L, Rogers AB, Lindquist S. Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis. Cell. 2007; 130(6):1005-18. Epub 2007/09/25. doi: 10.1016/j.cell.2007.07.020 PMID: 17889646; PubMed Central PMCID: PMC2586609.